TeraRecon Launches Updated Intuition 4.10 Cardiac MRI Software
The updated software reportedly provides access to more than 200 enhanced features including optimized hanging protocols with a cardiac MRI viewer and perfusion quantification analysis.
Offering a range of enhanced features to facilitate precision with cardiac magnetic resonance imaging (MRI), TeraRecon has launched an updated version of its software-as-a-service (SaaS) platform Intuition 4.10.
In addition to facilitating expedited measurements and reporting on cardiac MRI cases, the Intuition 4.10 software provides a dedicated cardiac MRI viewer with hanging protocols and over 200 enhanced features, according to TeraRecon.
The updated software-as-a-service (SaaS) platform Intuition 4.10 from TeraRecon reportedly offers more than 200 enhanced features for cardiac MRI assessment and workflow. (Images courtesy of Adobe Stock.)
The company added that features such as extracellular volume (ECV) mapping, 2D flow analysis and a new global strain analysis workflow provide significant quantification tools for cardiac MRI analysis.
"TeraRecon's Intuition 4.10 release includes significant new enhancements to cardiac MR workflows," noted Christopher Maroules, M.D., the chief of cardiothoracic imaging at the Naval Medical Center Portsmouth in Portsmouth, Va. “This release allows me to start standardizing my post-processing cardiac workflows onto a single, broad tool for imaging workflows. The versatility of the dedicated cardiac MR viewer and various cardiac MR workflows enable me to conduct my day-to-day cardiac MR analysis in a streamlined and consistent manner."
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
